Literature DB >> 16132351

Bile increases intestinal lymphatic drug transport in the fasted rat.

Natalie L Trevaskis1, Christopher J H Porter, William N Charman.   

Abstract

PURPOSE: This study was conducted to determine the influence of (1) the source of recruited endogenous fatty acid (FA), and (2) bile on intestinal lymphatic transport of halofantrine (Hf) in fasted rats.
METHODS: Endogenous FA output in bile, and exogenous ((14)C radiolabeled) FA, endogenous FA, and Hf transport in mesenteric lymph were determined following administration of low dose lipid formulations containing either 4 or 40 mg of exogenous FA [oleic acid (OA)] and different amounts of bile salt (BS) and lysophosphatidylcholine (LPC) to fasted rats.
RESULTS: Administration of 40 mg of OA recruited endogenous FA and Hf transport into intestinal lymph, whereas 4 mg OA did not. However, addition of BS to the 4-mg OA dose led to stimulation of endogenous FA recruitment into lymph and an increase in lymphatic transport of Hf and endogenous FA output in bile. Addition of LPC to the 4-mg OA dose (dispersed in BS) caused a substantial increase in endogenous FA transport in lymph; however, no coincident increase in either lymphatic transport of Hf or endogenous FA output in bile was observed.
CONCLUSION: Biliary-derived endogenous FA has a higher propensity to support lymphatic transport of Hf compared to other sources of endogenous FA. The results suggest that this is related to the disparate trafficking of these alternate sources of endogenous FA within the enterocyte.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132351     DOI: 10.1007/s11095-005-6808-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

1.  Effect of bile on absorption of mepitiostane by the lymphatic system in rats.

Authors:  T Ichihashi; H Kinoshita; Y Takagishi; H Yamada
Journal:  J Pharm Pharmacol       Date:  1992-07       Impact factor: 3.765

2.  Physico-chemical state of lipids in intestinal content during their digestion and absorption.

Authors:  A F HOFMANN; B BORGSTROM
Journal:  Fed Proc       Date:  1962 Jan-Feb

3.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

Authors:  C J Porter; S A Charman; W N Charman
Journal:  J Pharm Sci       Date:  1996-04       Impact factor: 3.534

4.  The entry of foreign compounds into the thoracic duct lymph of the rat.

Authors:  S M Sieber; V H Cohn; W T Wynn
Journal:  Xenobiotica       Date:  1974-05       Impact factor: 1.908

5.  A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.

Authors:  S M Khoo; G A Edwards; C J Porter; W N Charman
Journal:  J Pharm Sci       Date:  2001-10       Impact factor: 3.534

6.  Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat.

Authors:  R O Scow; Y Stein; O Stein
Journal:  J Biol Chem       Date:  1967-11-10       Impact factor: 5.157

7.  Factors influencing triacylglycerol delivery into mesenteric lymph.

Authors:  C M Mansbach; A Arnold; M A Cox
Journal:  Am J Physiol       Date:  1985-11

Review 8.  Formation and transport of chylomicrons by enterocytes to the lymphatics.

Authors:  P Tso; J A Balint
Journal:  Am J Physiol       Date:  1986-06

9.  Intracellular movement of triacylglycerols in the intestine.

Authors:  C M Mansbach; P Nevin
Journal:  J Lipid Res       Date:  1998-05       Impact factor: 5.922

10.  Role of biliary lecithin in lymphatic transport of fat.

Authors:  P Tso; J A Balint; W J Simmonds
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

View more
  10 in total

1.  Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Authors:  Natalie L Trevaskis; David M Shackleford; William N Charman; Glenn A Edwards; Anne Gardin; Silke Appel-Dingemanse; Olivier Kretz; Bruno Galli; Christopher J H Porter
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

2.  A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.

Authors:  Natalie L Trevaskis; Suzanne M Caliph; Gary Nguyen; Patrick Tso; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

3.  The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.

Authors:  Natalie L Trevaskis; Luojuan Hu; Suzanne M Caliph; Sifei Han; Christopher J H Porter
Journal:  J Vis Exp       Date:  2015-03-06       Impact factor: 1.355

4.  An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats.

Authors:  Natalie L Trevaskis; Chun Min Lo; Li Yun Ma; Patrick Tso; Helen R Irving; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug.

Authors:  Sifei Han; Luojuan Hu; Tim Quach; Jamie S Simpson; Natalie L Trevaskis; Christopher J H Porter
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

6.  The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles.

Authors:  Natalie L Trevaskis; Ravi M Shanker; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2010-07-16       Impact factor: 4.200

7.  A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice.

Authors:  Claude Emond; Michael J DeVito; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-11       Impact factor: 4.460

Review 8.  The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.

Authors:  Jamal Khan; Thomas Rades; Ben Boyd
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

Review 9.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

Review 10.  Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.

Authors:  Natalie L Trevaskis; William N Charman; Christopher J H Porter
Journal:  Adv Drug Deliv Rev       Date:  2007-11-07       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.